Secondary Prophylaxis of Cirrhotic Gastric Variceal Bleeding: Addition of Non‐Selective Beta‐Blockers to Endoscopic Combined Treatment
We show for the first time that adding NSBB to combined endoscopic therapy significantly reduced recurrent variceal bleeding in cirrhotic patients but did not improve overall survival, except for patients without splenectomy. The addition of NSBB for patients receiving combined endoscopic treatment of gastroesophageal varices provides benefits but does not prolong overall survival.
Authors
- Detlef Schuppan (ORCID: https://orcid.org/0000-0002-4972-1293)
- Xiaoquan Huang (ORCID: https://orcid.org/0000-0002-8752-4899)
- Siyu Jiang (ORCID: https://orcid.org/0000-0002-2944-0750)
- Liyuan Ni (ORCID: https://orcid.org/0000-0001-5334-1317)
- Ling Wu (ORCID: https://orcid.org/0000-0001-6574-6493)
- Yingjie Ai (ORCID: https://orcid.org/0000-0001-6309-1892)
- Feng Li (ORCID: https://orcid.org/0000-0001-7423-8730)
- Shiyao Chen (ORCID: https://orcid.org/0000-0003-0845-3752)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Sun Yat-sen University (CN)
- Johannes Gutenberg University Mainz (DE)
- Fudan University (CN)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- United European Gastroenterology Journal
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1002/ueg2.12739
- Citations
- 3
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- Deutsche Forschungsgemeinschaft
- National Key Research and Development Program of China
- HORIZON EUROPE European Research Council